Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Selective beta3-adrenoceptor agonists in Dainippon's pipeline

July 26, 1996

Ibex licenses technology from Centre for Applied Microbiology and Research

July 26, 1996

Celtrix's SomatoKine proven safe in phase I

July 26, 1996

SR-12813: SmithKline Beecham and Symphar's hypocholesterolemic drug

July 26, 1996

Patent collaboration on bone morphogenetic/osteogenetic proteins

July 26, 1996

Boehringer Mannheim reveals acatelin, a novel ACAT inhibitor

July 26, 1996

Isolation of SOX-9 polypeptide encoding gene announced

July 26, 1996

Didronel receives 22nd marketing approval

July 19, 1996

Lea's Shield demonstrates contraceptive efficacy and safety

July 19, 1996

High continuation rate demonstrated for Norplant in first year of use

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 24, 2025.
Regulatory actions for April 24, 2025
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cel-Sci, Novavax,...
Go ask Alis? New fund aims to rescue biopharma’s trapped cash
BioWorld
“They are not zombies, they are fallen angels.” That is view of Nick Johnston, a U.K-based banker who has come up with a new plan to rescue listed companies whose...
Synthetic Design emerges with $20M and next-gen ADC platform
BioWorld
Synthetic Design Lab Inc., which emerged from stealth with a $20 million seed round and a platform technology aimed at advancing the antibody-drug conjugate (ADC)...